Mumbai: Nita M. Ambani, Founder and Chairperson of Reliance Foundation, announced the launch of a New Health Seva Plan that prioritises essential screenings and treatments for children, adolescent girls and women.  As part of this New Health Seva Plan, Nita Ambani has pledged free screening and treatment for congenital heart disease amongst 50,000 children, free screening and treatment of breast and cervical cancer amongst 50,000 women and free cervical cancer vaccination for 10,000 adolescent girls to commemorate the 10^th anniversary of Sir H. N. Reliance Foundation Hospital.

Nita M. Ambani, Founder and Chairperson of Reliance Foundation, said, “For 10 years, Sir H. N. Reliance Foundation Hospital has been driven by our vision to make world-class healthcare accessible and affordable to every Indian. Together, we have touched millions of lives and offered hope to countless families. As we celebrate this milestone, we have launched a New Health Seva Plan, free of cost, for children and women from marginalized communities. For we believe that good health is the foundation of a prosperous nation, and healthy women and children are the bedrock of a thriving society.”

Sir H. N. Reliance Foundation Hospital has completed a decade of providing healthcare services. In the past decade, the Hospital has touched the lives of 2.75 million Indians, including over 1.5 lakh children. The Hospital has conducted more than 500 organ transplants, and hold the record for transplanting 6 organs within 24 hours saving multiple lives. Sir H. N. Reliance Foundation Hospital has also been recognized as the No. 1 Multi-Specialty Hospital in India consistently.

Congenital heart disease is a critical public health issue in India, with significant morbidity and mortality rates. It affects nearly 1 in 100 new-borns in the country. At the same time, breast cancer is the most prevalent cancer among Indian women, comprising more than 25% of all female cancers. A recent ICMR study noted that patients diagnosed at a local stage have a 4.4 times greater chance of five-year survival compared to those with distant-stage cancer, making timely diagnosis and access to treatment key to better outcomes for these patients. The projected cervical cancer burden for India in 2025 is estimated to be 1.5 million disability-adjusted life days, as per a pubmed study. DeshGujarat